WS Data Solutions
Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Buy
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Neutral
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Inhibikase Therapeutics, Inc. Common Stock (IKT)
Biological Products, (no Disgnostic Substances)
Inhibikase Therapeutics Inc is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease and related disorders. Its multi-therapeutic pipeline focuses on neurodegeneration and its program for IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, intends to treat Parkinson's disease inside and outside the brain. The company is performing its Phase I, randomized single ascending dose and multiple ascending dose, study to determine the safety, tolerability and pharmacokinetics of IkT-148009 in older and healthy subjects. It is also advancing a novel drug delivery platform to treat certain forms of cancer at the same time as it is developing novel drugs for the treatment of neurodegenerative disease.
3350 RIVERWOOD PARKWAY SE, SUITE 1900
ATLANTA, GA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
12/23/2020
Market Cap
8,984,107
Shares Outstanding
6,170,000
Weighted SO
6,174,280
Total Employees
N/A
Upcoming Earnings
08/12/2024
Beta
1.3300
Last Div
0.0000
Range
0.79-3.82
Chg
-0.0350
Avg Vol
26483
Mkt Cap
8984107
Exch
NASDAQ
Country
US
Phone
678 392 3419
DCF Diff
0.9265
DCF
0.3185
Div Yield
0.0000
P/S
112.9082
EV Multiple
-0.3201
P/FV
1.8408
Div Yield %
0.0000
P/E
-0.5104
PEG
-0.0308
Payout
0.0000
Current Ratio
2.3222
Quick Ratio
2.3222
Cash Ratio
0.8332
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
18623.5439
CCC
-18623.5439
Gross Margin
0.6698
Op Margin
-238.8506
Pretax Margin
-231.0215
Net Margin
-231.0215
Eff Tax Rate
-0.0025
ROA
-2.0826
ROE
-1.9417
ROCE
-3.7103
NI/EBT
1.0000
EBT/EBIT
0.9672
EBIT/Rev
-238.8506
Debt Ratio
0.0201
D/E
0.0349
LT Debt/Cap
0.0050
Total Debt/Cap
0.0337
Int Coverage
28.7261
CF/Debt
-92.6104
Equity Multi
1.7319
Rec Turnover
0.0000
Pay Turnover
0.0196
Inv Turnover
0.0000
FA Turnover
0.3552
Asset Turnover
0.0090
OCF/Share
-2.1855
FCF/Share
-2.1836
Cash/Share
1.0537
OCF/Sales
-206.9739
FCF/OCF
0.9991
CF Coverage
-92.6104
ST Coverage
-108.1887
CapEx Coverage
-1156.6875
Div&CapEx Cov
-1156.6875
P/BV
1.8408
P/B
1.8408
P/S
112.9082
P/E
-0.5104
P/FCF
-0.5460
P/OCF
-0.5697
P/CF
-0.5697
PEG
-0.0308
P/S
112.9082
EV Multiple
-0.3201
P/FV
1.8408
DPS
0.0000